Julius Limos Decano, M.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Systems Analysis | 1 | 2021 | 166 | 0.770 |
Why?
|
| Vena Cava, Inferior | 2 | 2021 | 449 | 0.760 |
Why?
|
| PPAR alpha | 1 | 2021 | 195 | 0.750 |
Why?
|
| Vascular Grafting | 1 | 2021 | 163 | 0.710 |
Why?
|
| Macrophages | 4 | 2021 | 5814 | 0.600 |
Why?
|
| Receptors, Endothelin | 3 | 2011 | 64 | 0.540 |
Why?
|
| Calcinosis | 1 | 2022 | 1456 | 0.480 |
Why?
|
| Vasculitis | 1 | 2016 | 518 | 0.450 |
Why?
|
| Vasa Vasorum | 1 | 2011 | 31 | 0.440 |
Why?
|
| Receptor, Endothelin A | 1 | 2011 | 61 | 0.440 |
Why?
|
| Protective Agents | 1 | 2013 | 165 | 0.430 |
Why?
|
| Microbubbles | 1 | 2011 | 119 | 0.410 |
Why?
|
| Aortic Valve Stenosis | 1 | 2022 | 1855 | 0.380 |
Why?
|
| Cholesterol Ester Transfer Proteins | 2 | 2011 | 123 | 0.360 |
Why?
|
| Receptors, Vascular Endothelial Growth Factor | 1 | 2011 | 652 | 0.340 |
Why?
|
| Hypertension | 5 | 2023 | 8285 | 0.320 |
Why?
|
| Macrophage Activation | 2 | 2022 | 592 | 0.320 |
Why?
|
| Sodium Chloride, Dietary | 1 | 2009 | 258 | 0.310 |
Why?
|
| Proteomics | 4 | 2022 | 3268 | 0.310 |
Why?
|
| Rats, Inbred Dahl | 4 | 2016 | 48 | 0.300 |
Why?
|
| Sex Characteristics | 2 | 2016 | 2542 | 0.280 |
Why?
|
| Receptors, Angiotensin | 4 | 2010 | 144 | 0.280 |
Why?
|
| Hyperlipidemias | 2 | 2011 | 805 | 0.270 |
Why?
|
| Neovascularization, Pathologic | 2 | 2014 | 2716 | 0.260 |
Why?
|
| Molecular Imaging | 1 | 2011 | 853 | 0.260 |
Why?
|
| Stroke | 5 | 2023 | 9510 | 0.260 |
Why?
|
| Endothelial Cells | 3 | 2015 | 3433 | 0.250 |
Why?
|
| Rats, Transgenic | 3 | 2011 | 73 | 0.230 |
Why?
|
| Myocardial Infarction | 1 | 2022 | 11424 | 0.200 |
Why?
|
| Atherosclerosis | 2 | 2019 | 3262 | 0.200 |
Why?
|
| Carotid Arteries | 3 | 2015 | 965 | 0.200 |
Why?
|
| Rats | 9 | 2023 | 25092 | 0.190 |
Why?
|
| Indican | 1 | 2019 | 19 | 0.180 |
Why?
|
| Intercellular Signaling Peptides and Proteins | 2 | 2019 | 1752 | 0.180 |
Why?
|
| Stem Cells | 1 | 2013 | 3597 | 0.180 |
Why?
|
| Receptors, Vasopressin | 2 | 2010 | 119 | 0.180 |
Why?
|
| Organic Anion Transporters | 1 | 2019 | 90 | 0.170 |
Why?
|
| Brain Ischemia | 1 | 2013 | 3309 | 0.170 |
Why?
|
| Contrast Media | 1 | 2011 | 5278 | 0.170 |
Why?
|
| Extracellular Matrix Proteins | 1 | 2022 | 850 | 0.160 |
Why?
|
| Intracellular Signaling Peptides and Proteins | 2 | 2019 | 3010 | 0.150 |
Why?
|
| Neointima | 1 | 2015 | 146 | 0.130 |
Why?
|
| Osteogenesis | 1 | 2022 | 1290 | 0.130 |
Why?
|
| Animals | 17 | 2023 | 170894 | 0.130 |
Why?
|
| Crosses, Genetic | 1 | 2016 | 841 | 0.130 |
Why?
|
| Leukocytes, Mononuclear | 1 | 2021 | 1737 | 0.130 |
Why?
|
| Anoikis | 1 | 2014 | 49 | 0.130 |
Why?
|
| Aging | 1 | 2013 | 8376 | 0.120 |
Why?
|
| Receptors, Notch | 1 | 2019 | 761 | 0.120 |
Why?
|
| Blood Pressure | 3 | 2016 | 8582 | 0.120 |
Why?
|
| Saphenous Vein | 1 | 2015 | 518 | 0.110 |
Why?
|
| Receptors, LDL | 3 | 2022 | 543 | 0.110 |
Why?
|
| Microscopy, Phase-Contrast | 1 | 2011 | 130 | 0.110 |
Why?
|
| Aortic Valve | 1 | 2022 | 1835 | 0.110 |
Why?
|
| Kidney Concentrating Ability | 1 | 2010 | 41 | 0.100 |
Why?
|
| Brain Injuries | 1 | 2023 | 1924 | 0.100 |
Why?
|
| Mice, Knockout | 4 | 2021 | 15258 | 0.100 |
Why?
|
| Antigens, CD34 | 1 | 2013 | 673 | 0.100 |
Why?
|
| Autophagy | 2 | 2009 | 1347 | 0.100 |
Why?
|
| Graft Survival | 1 | 2021 | 3765 | 0.100 |
Why?
|
| Microvessels | 2 | 2014 | 567 | 0.100 |
Why?
|
| Membrane Proteins | 2 | 2019 | 8109 | 0.090 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 3 | 2013 | 4935 | 0.090 |
Why?
|
| Genome | 2 | 2016 | 1755 | 0.090 |
Why?
|
| Pseudogenes | 2 | 2023 | 118 | 0.090 |
Why?
|
| Ultrasonography | 3 | 2014 | 5948 | 0.090 |
Why?
|
| Haploidy | 1 | 2009 | 155 | 0.090 |
Why?
|
| Quantitative Trait Loci | 1 | 2016 | 1979 | 0.080 |
Why?
|
| Cells, Cultured | 2 | 2022 | 20097 | 0.080 |
Why?
|
| Animals, Genetically Modified | 1 | 2013 | 1593 | 0.080 |
Why?
|
| Receptors, Peptide | 1 | 2009 | 269 | 0.080 |
Why?
|
| Mice, Inbred C57BL | 4 | 2021 | 22929 | 0.080 |
Why?
|
| Fluorescent Antibody Technique | 1 | 2011 | 2669 | 0.080 |
Why?
|
| MicroRNAs | 1 | 2022 | 3680 | 0.080 |
Why?
|
| Aorta | 1 | 2014 | 2114 | 0.070 |
Why?
|
| Disease Models, Animal | 4 | 2019 | 18353 | 0.070 |
Why?
|
| Neoplastic Stem Cells | 1 | 2014 | 1391 | 0.070 |
Why?
|
| Renal Insufficiency, Chronic | 1 | 2019 | 1994 | 0.070 |
Why?
|
| Sodium-Potassium-Exchanging ATPase | 1 | 2007 | 495 | 0.060 |
Why?
|
| Microcirculation | 1 | 2009 | 1302 | 0.060 |
Why?
|
| Receptors, Cytoplasmic and Nuclear | 1 | 2009 | 864 | 0.060 |
Why?
|
| Microscopy, Fluorescence | 1 | 2011 | 2816 | 0.060 |
Why?
|
| Receptors, Cell Surface | 1 | 2014 | 2918 | 0.060 |
Why?
|
| Analysis of Variance | 1 | 2013 | 6529 | 0.060 |
Why?
|
| Receptors, G-Protein-Coupled | 1 | 2010 | 1207 | 0.060 |
Why?
|
| Subtilisins | 1 | 2022 | 89 | 0.060 |
Why?
|
| Humans | 13 | 2022 | 717280 | 0.060 |
Why?
|
| Mice | 6 | 2022 | 81128 | 0.060 |
Why?
|
| Carotid Artery Diseases | 1 | 2009 | 916 | 0.060 |
Why?
|
| Calcium-Binding Proteins | 2 | 2019 | 1098 | 0.060 |
Why?
|
| Heterozygote | 1 | 2009 | 2794 | 0.050 |
Why?
|
| Flow Cytometry | 1 | 2013 | 6134 | 0.050 |
Why?
|
| Epigenesis, Genetic | 1 | 2014 | 3471 | 0.050 |
Why?
|
| Proteome | 1 | 2011 | 1776 | 0.050 |
Why?
|
| Haplotypes | 1 | 2007 | 2883 | 0.050 |
Why?
|
| Phenotype | 3 | 2019 | 16404 | 0.050 |
Why?
|
| Lipoproteins, LDL | 1 | 2022 | 668 | 0.040 |
Why?
|
| COS Cells | 2 | 2014 | 1211 | 0.040 |
Why?
|
| Glioblastoma | 1 | 2014 | 3357 | 0.040 |
Why?
|
| Male | 10 | 2023 | 351399 | 0.040 |
Why?
|
| Inflammation Mediators | 2 | 2019 | 1948 | 0.040 |
Why?
|
| Sex Factors | 2 | 2009 | 10661 | 0.040 |
Why?
|
| Maze Learning | 2 | 2010 | 497 | 0.040 |
Why?
|
| Serine Endopeptidases | 1 | 2022 | 1136 | 0.040 |
Why?
|
| Pancreatic Neoplasms | 1 | 2014 | 5022 | 0.040 |
Why?
|
| Anxiety | 1 | 2010 | 3924 | 0.040 |
Why?
|
| Adaptor Proteins, Signal Transducing | 2 | 2019 | 3008 | 0.040 |
Why?
|
| Hippocampus | 1 | 2008 | 3660 | 0.030 |
Why?
|
| Treatment Outcome | 1 | 2022 | 62344 | 0.030 |
Why?
|
| Female | 8 | 2023 | 377934 | 0.030 |
Why?
|
| Tunica Media | 1 | 2014 | 124 | 0.030 |
Why?
|
| Rats, Nude | 1 | 2014 | 111 | 0.030 |
Why?
|
| Cerebral Cortex | 1 | 2011 | 5728 | 0.030 |
Why?
|
| Ligands | 2 | 2014 | 3334 | 0.030 |
Why?
|
| Cognition Disorders | 1 | 2008 | 3990 | 0.030 |
Why?
|
| Magnetic Resonance Imaging | 2 | 2013 | 34503 | 0.030 |
Why?
|
| NF-kappa B | 1 | 2022 | 2584 | 0.030 |
Why?
|
| Transfection | 2 | 2015 | 6142 | 0.030 |
Why?
|
| Cholesterol | 1 | 2022 | 2894 | 0.030 |
Why?
|
| Cognition | 1 | 2010 | 6109 | 0.030 |
Why?
|
| Brain Neoplasms | 1 | 2014 | 8805 | 0.030 |
Why?
|
| Age Factors | 1 | 2009 | 18798 | 0.030 |
Why?
|
| Genetic Predisposition to Disease | 2 | 2014 | 17432 | 0.030 |
Why?
|
| Cerebral Hemorrhage | 1 | 2023 | 2567 | 0.030 |
Why?
|
| Sodium, Dietary | 1 | 2014 | 413 | 0.030 |
Why?
|
| Myocytes, Smooth Muscle | 1 | 2015 | 735 | 0.030 |
Why?
|
| Aquaporin 4 | 1 | 2011 | 125 | 0.020 |
Why?
|
| Neuroepithelial Cells | 1 | 2009 | 24 | 0.020 |
Why?
|
| Laminin | 1 | 2011 | 421 | 0.020 |
Why?
|
| Neural Tube | 1 | 2009 | 51 | 0.020 |
Why?
|
| Neurons | 1 | 2008 | 9442 | 0.020 |
Why?
|
| DNA | 1 | 2022 | 7166 | 0.020 |
Why?
|
| Muscle, Smooth, Vascular | 1 | 2015 | 1621 | 0.020 |
Why?
|
| Cell Communication | 1 | 2015 | 1657 | 0.020 |
Why?
|
| Diagnostic Imaging | 1 | 2022 | 3496 | 0.020 |
Why?
|
| Transcription Initiation Site | 1 | 2008 | 192 | 0.020 |
Why?
|
| Plaque, Atherosclerotic | 1 | 2019 | 1381 | 0.020 |
Why?
|
| Antibodies | 1 | 2015 | 2442 | 0.020 |
Why?
|
| Polymorphism, Single Nucleotide | 1 | 2007 | 15600 | 0.020 |
Why?
|
| Signal Transduction | 3 | 2019 | 23997 | 0.020 |
Why?
|
| Vasopressins | 1 | 2008 | 372 | 0.020 |
Why?
|
| Cell Proliferation | 2 | 2015 | 10802 | 0.020 |
Why?
|
| RNA Interference | 1 | 2015 | 3020 | 0.020 |
Why?
|
| Xenograft Model Antitumor Assays | 1 | 2014 | 3697 | 0.020 |
Why?
|
| Neoplasm Invasiveness | 1 | 2014 | 3704 | 0.020 |
Why?
|
| Brain | 2 | 2009 | 25281 | 0.020 |
Why?
|
| Tandem Mass Spectrometry | 1 | 2011 | 1120 | 0.020 |
Why?
|
| Angiotensin II | 1 | 2008 | 921 | 0.020 |
Why?
|
| Gonadal Steroid Hormones | 1 | 2008 | 689 | 0.020 |
Why?
|
| Cell Survival | 1 | 2014 | 6133 | 0.010 |
Why?
|
| Protein Isoforms | 1 | 2008 | 1711 | 0.010 |
Why?
|
| Organ Specificity | 1 | 2008 | 2049 | 0.010 |
Why?
|
| Cell Movement | 1 | 2015 | 5465 | 0.010 |
Why?
|
| Linkage Disequilibrium | 1 | 2007 | 2065 | 0.010 |
Why?
|
| Microscopy, Confocal | 1 | 2008 | 2043 | 0.010 |
Why?
|
| Ischemia | 1 | 2011 | 1955 | 0.010 |
Why?
|
| Social Behavior | 1 | 2008 | 1117 | 0.010 |
Why?
|
| Endothelium, Vascular | 1 | 2014 | 4636 | 0.010 |
Why?
|
| Neovascularization, Physiologic | 1 | 2009 | 1423 | 0.010 |
Why?
|
| Time Factors | 2 | 2015 | 41094 | 0.010 |
Why?
|
| Cerebrovascular Circulation | 1 | 2011 | 2755 | 0.010 |
Why?
|
| Behavior, Animal | 1 | 2008 | 1915 | 0.010 |
Why?
|
| Gene Frequency | 1 | 2007 | 3714 | 0.010 |
Why?
|
| Blotting, Western | 1 | 2008 | 5438 | 0.010 |
Why?
|
| Phosphorylation | 1 | 2010 | 8744 | 0.010 |
Why?
|
| Cell Differentiation | 1 | 2015 | 11762 | 0.010 |
Why?
|
| Regression Analysis | 1 | 2007 | 6480 | 0.010 |
Why?
|
| Cell Line, Tumor | 1 | 2014 | 16989 | 0.010 |
Why?
|
| Immunohistochemistry | 1 | 2011 | 11777 | 0.010 |
Why?
|
| Peptides | 1 | 2008 | 4438 | 0.010 |
Why?
|
| Protein Binding | 1 | 2008 | 9665 | 0.010 |
Why?
|
| Transcription, Genetic | 1 | 2008 | 7952 | 0.010 |
Why?
|
| RNA, Messenger | 1 | 2008 | 13301 | 0.010 |
Why?
|
| Gene Expression Regulation | 1 | 2008 | 12435 | 0.010 |
Why?
|
| Mutation | 1 | 2008 | 29491 | 0.000 |
Why?
|